 The risk of thromboembolism in asymptomatic patientsw i t hp r o t e i nCa n dp r o t e i nSd e ﬁ c i e n cy: a prospective cohort study.
Thromb Haemost 1994; 71: 441–5.
23 Lensen R, Rosendaal F, Vandenbroucke J, Bertina R. Factor V
Leiden: the venous thrombotic ri sk in thrombophilic families. Br J
Haematol 2000; 110: 939–45.
24 Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P,
Girolami A. Incidence of venous thromboembolism in asymptomaticfamily members who are carriers of factor V Leiden: a prospectivecohort study. Blood 2002; 99: 1938–42.
25 Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC,
Hamulya ´kK ,v a nd e rM e e rJ ,P r i n sM H ,B u ¨ller HR. A prospective
study of asymptomatic carriers of the factor V Leiden mutation to
determine the incidence of venous thromboembolism. A n nI n t e r nM e d
2001; 135: 322–7.
26 van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Brie ¨tE .
Bleeding complications in oral anticoagulant therapy. An analysis of
risk factors. Arch Intern Med 1993; 153: 1557–62.
2 7 P a l a r e t iG ,L e a l iN ,C o c c h e r iS ,P o g g iM ,M a n o t t iC ,D ’ A n g e l oA ,
Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M,Musolesi S. Bleeding complications of oral anticoagulant treatment:
an inception-cohort, prospective collaborative study (ISCOAT).
Italian Study on Comp lications of Oral Anticoagulant Therapy.
Lancet 1996; 348: 423–8.464 C. Y. Vossen et al
/C2112005 International Society on Thrombosis and Haemostasis
 15387836, 2005, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2005.01197.x by Readcube (Labtiva Inc.), Wiley Online Library on [25/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License